These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 26482475)

  • 1. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B
    Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.
    Guerrero-Setas D; Pérez-Janices N; Blanco-Fernandez L; Ojer A; Cambra K; Berdasco M; Esteller M; Maria-Ruiz S; Torrea N; Guarch R
    Mod Pathol; 2013 Aug; 26(8):1111-22. PubMed ID: 23542458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.
    Guo W; Wang C; Guo Y; Shen S; Guo X; Kuang G; Dong Z
    Clin Exp Metastasis; 2015 Jan; 32(1):83-98. PubMed ID: 25579665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma.
    Zhu J; Ling Y; Xu Y; Lu MZ; Liu YP; Zhang CS
    Int J Clin Exp Pathol; 2015; 8(11):14392-400. PubMed ID: 26823755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherens junctions associated protein 1 serves as a predictor of recurrence of squamous cell carcinoma of the esophagus.
    Tanaka H; Kanda M; Koike M; Iwata N; Shimizu D; Ezaka K; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Int J Oncol; 2015 Nov; 47(5):1811-8. PubMed ID: 26397940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
    Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W
    Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
    Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Shen S; Guo X; Kuang G; Yang Z
    Mol Carcinog; 2016 Nov; 55(11):1655-1666. PubMed ID: 26456015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.
    Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y
    Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
    Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
    J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
    J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter 2 methylation‑mediated downregulation of protein tyrosine phosphatase, non‑receptor type 6, is associated with progression of esophageal squamous cell carcinoma.
    Liu L; Zhang S; Liu X; Liu J
    Mol Med Rep; 2019 Apr; 19(4):3273-3282. PubMed ID: 30816454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
    Sun N; Ye L; Chang T; Li X; Li X
    Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
    Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
    Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.
    Li LW; Yu XY; Yang Y; Zhang CP; Guo LP; Lu SH
    Int J Cancer; 2009 Oct; 125(7):1505-13. PubMed ID: 19521989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.